ClinicalTrials.Veeva

Menu

Transcranial Direct Current Stimulation (tDCS) in the Treatment of Drug-naïve Obsessive-compulsive Disorder(OCD)

S

Shanghai Mental Health Center

Status

Completed

Conditions

Obsessive-Compulsive Disorder

Treatments

Device: Sham tDCS
Device: high-definition transcranial direct current stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04086446
SMHC-OCD-004

Details and patient eligibility

About

This study will evaluate the possible therapeutic effects of Transcranial Direct Current Stimulation (tDCS) in drug-naïve obsessive-compulsive disorder (OCD) patients, and the underlying neural mechanism by magnetic resonance imaging (MRI),transcranial magnetic stimulation and electroencephalography (TMS-EEG).

Full description

The purpose of this study is to examine the efficacy of tDCS over orbitofrontal cortex (OFC) in treatment of drug-naïve OCD patients. 60 drug-naïve OCD patients will be randomized into two groups (i.e. active or sham stimulation). tDCS stimulation will be performed once a day, five times a week, for two weeks. The investigators will assess symptom severity before and after two weeks of tDCS. Through the study, Yale-Brown Obsessive Compulsive Scale(Y-BOCS), the Obsessive Compulsive Inventory-Revised (OCI-R), the Beck Depression Inventory (BDI), the Beck Anxiety Inventory (BAI), Perceived Stress Scale (PSS), Pittsburgh sleep quality index (PSQI)and side-effect questionnaire will be obtained by a trained investigator. The patients will also receive MRI scan and TMS-EEG.

Enrollment

47 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age: 18-50 years old;
  • DSM-5 criteria for OCD;
  • Y-BOCS total score > or = 16, discontinued medication for at least 8 weeks before tDCS stimulation.
  • >or=9 years education

Exclusion criteria

  • Any axis I psychiatric disorder comorbidity
  • The inability to receive tDCS because of metallic implants, or history of seizures,or 3.history of head injury, or history of neurosurgery.
  • Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.
  • Any current significant medical condition.
  • serious suicide risk

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

47 participants in 2 patient groups

active tDCS
Active Comparator group
Description:
Cathode transcranial direct current stimulation over the right OFC will be applied once a day, 5 days a week, for 2 weeks.
Treatment:
Device: high-definition transcranial direct current stimulation
sham tDCS
Sham Comparator group
Description:
The sham transcranial direct current stimulation over the right OFC will be applied once a day, 5 days a week, for 2 weeks.
Treatment:
Device: Sham tDCS

Trial contacts and locations

1

Loading...

Central trial contact

Zhen Wang, PhD,MD; Zhen Wang, PhD,MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems